Site icon OncologyTube

Discussing REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib

Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com

Exit mobile version